Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - matthias hammers
Recombinant antibody fragments for targeted treatment of autoimmune skin disease
Recombinant antibodies for diagnosis, treatment, and targeted drug delivery in skin disease. Technology Overview: Bullous pemphigoid (BP) is an autoantibody-mediated blistering skin disease in which the epidermal cells lose adhesion to the basement membrane. Patients feature circulating and tissue-bound autoantibodies that target two basement...
Therapeutics & Vaccines
© 2020. All Rights Reserved. Powered by